Advisory Services Network’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Advisory Services Network’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-60	Closed	-$2K	–	3206
2020 Q4	$2K	Buy	+60	New	+$2.99K	﹤0.01%	3082
2020 Q3	–	Hold	0	–	–	–	3695
2020 Q2	–	Hold	0	–	–	–	2968
2020 Q1	–	Hold	0	–	–	–	3375

Other funds holding TMBR

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisory Services Network's TMBR Position: Q1 2021 in Review

Advisory Services Network sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2021, closing a stake of 60 shares — an estimated $2K sold.

Advisory Services Network first reported a position in TMBR in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 13 funds tracked by Wall St. Rank hold TMBR as of Q1 2021.

Advisory Services Network reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
Advisory Services Network sold 60 Timber Pharmaceuticals, Inc. shares in Q1 2021, an estimated $2K.
Advisory Services Network first reported a position in Timber Pharmaceuticals, Inc. in Q4 2020 and held it in 1 quarter.
Advisory Services Network's Timber Pharmaceuticals, Inc. position peaked at $2K in Q4 2020.
13 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2021.

Based on Advisory Services Network's 13F filing for Q1 2021, filed 24 May 2021.